Cashless Transactions - Mark of the Beast

CDMOs Gear Up to Churn Out Cell and Gene Therapies. ‘As in the days of Noah, ALL FLESH had become corrupted, defiled or unclean.’

Ezekiel 33:6

But if the watchman see the sword come, and blow not the trumpet, and the people be not warned; if the sword come, and take any person from among them, he is taken away in his iniquity; but his blood will I require at the watchman’s hand.

The Coming Biometric Vaccination Mark of the Beast System:

(Five (5); Digital ID, Vaccination Passport, Biometric Infrared Scanning, Vaccine ‘Mark’ or ‘code/number’ of Approval or Authorization, 5G Technology/Network.)

The ‘coming’ mark will most likely involve a ‘subdermal’ (non-hypodermic needle) application of the next wave of vaccinations, that will include a form of ‘digital data memory’ indicating date and time of vaccination. This ‘mark’ of vaccination will involve a sub-dermal outline or image representing a ‘branding’ that can be scanned and revealed by infrared light at a retail checkout point scanner. Just as many people have a physical vaccination ‘mark’ on their arm from getting shots in the 1960s, the coming vaccination mark will be subtle and reside ‘inside’ the human body affecting and indicating a genomic change in the recipient. This is an abomination viewed by God and causes the recipient to lose ‘Imager Status before God’ and results in eternal damnation. The vaccination ‘mark’ has to be easily accessible by scanners and retail checkout points, hence the recipient will have the option of receiving the vaccination ‘patch’ either on their hand or forehead for ‘scannability.’ The patch or medium itself ‘dissolves’ on the exterior of the skin, as the vaccination and information is administered or delivered under the skin. Some technology is currently under development that will possibly allow for the recipient’s health status and response to the vaccine to be ‘scanned’ and ‘verified’ or ‘validated’ at retail or social checkpoints. The purpose of which is to identify whether or not the vaccine has actually worked (and is working) on the recipient’s body / immune system / genetics / RNA / DNA, in addition to informing authorities as to date, time, dosage and manufacturer of said ‘medicine.’

False Prophet

Revelation 13:16-17 And he causeth all, both small and great, rich and poor, free and bond, to receive a mark in their right hand, or in their foreheads: And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name.

Revelation 19:20 

And the beast was taken, and with him the false prophet that wrought miracles before him, with which he deceived them that had received the mark of the beast, and them that worshipped his image. These both were cast alive into a lake of fire burning with brimstone.

Revelation 14:11

And the smoke of their torment ascendeth up for ever and ever: and they have no rest day nor night, who worship the beast and his image, and whosoever receiveth the mark of his name.

Revelation 20:4

And I saw thrones, and they sat upon them, and judgment was given unto them: and I saw the souls of them that were beheaded for the witness of Jesus, and for the word of God, and which had NOT worshipped the beast, neither his image, neither had received his mark upon their foreheads, or in their hands; and they lived and reigned with Christ a thousand years.

5G + Biometric Facial / Hand Scanning + Digital / Cashless Transactions + Mark of Approval / Authorization = Tomorrow’s Economy (2020-2027). Why 2020? Because these ‘things’ have already occurred (past tense) elsewhere (China, India, Asia and a few countries in Europe) in the world in 2020, even though they have not yet occurred in the ‘United’ States.

Biometric scanning used for migrant/border control, secure identity verification and approval, government benefits, domestic and international travel security, economic inclusion of everyone, buying/selling transactions and fund transfers, instantaneous speed of transaction and convenience, VAT/taxation collection, mobility, social credit score and ranking, population movement and tracking, monitoring political and religious ‘extremism’ (terrorists). ‘Mark, number or name’ for verification and approval.

‘Any foreign material(s) should NOT be injected into the human body that causes any kind of change in genetic makeup or structure of a human being. This could be five (5) genetic ‘manipulation’, ‘enhancement’, ‘cutting’, ‘modification’, or ‘alteration.’

Revelation 16:2

And the first went, and poured out his vial upon the earth; and there fell a noisome and grievous sore upon the men which had the mark of the beast, and upon them which worshipped his image. [Symptom or result from having ‘received’ the mark, a result from having changed or damaged a person’s RNA, DNA, Immune System or Genetics].

Both American vaccines use messenger RNA (mRNA) to combat the virus. That is an advanced genetic therapy that uses the virus’ own genetic material against it. Kendrick, however, warns that the technology isreally new and untested, meaning no one really knows how it could affect human health, since it literally hijacks the cellular reproduction mechanism. “We really do not know what these things might end up doing after a prolonged period of time.”

“The plague year of 2020 will be remembered as the time when traditional vaccines were supplanted by something fundamentally new: genetic vaccines, which deliver a gene or piece of genetic code into human cells. The genetic instructions then cause the cells to produce, on their own, safe components of the target virus in order to stimulate the patient’s immune system.”

‘The MARK’ may not be here just yet, but it will be shortly … in terms of a year or two (2023). Verification that a ‘genetic manipulation’ has been administered and will be evident, either in the hand or in the forehead by infrared biometric scanning to enable travel, buying and selling. Do you still ‘want to take’ the jab even if it is not yet administered in your hand or in your forehead in some other manner? If you are curious, please read my other analyses on ‘why’ getting ‘the mark’ is such a bad (understatement) thing in the eyes of God. It is one thing to understand that people in the extremely near future should NOT GET THE MARK. It is another thing to UNDERSTAND WHY THEY SHOULD NOT GET A MARK. This is not a ‘conspiracy theory,’ but the Word of God. I have provided the requisite verses from the Bible, regarding God’s comments about ‘the mark’ of the coming world beast system.

NO ‘MICROCHIP’ NEEDED. Implantable Quantum Dot Microneedle Vaccine INFRARED Delivery System:

MIT researchers have now developed a novel way to record a patient’s vaccination history: storing the data in a pattern of dye, invisible to the naked eye, that is delivered under the skin at the same time as the vaccine. This technology could enable the rapid and anonymous detection of patient vaccination history. The researchers showed that their new dye, which consists of nanocrystals called quantum dots, can remain for at least five (5) years under the skin, where it emits [near-infrared light] that can be detected by a specially equipped smartphone. To create an “on-patient,” decentralized medical record, the researchers developed a new type of copper-based quantum dots, which emit light in the [near-infrared spectrum]. The dots are only about 4 nanometers in diameter, but they are encapsulated in biocompatible microparticles that form spheres about 20 microns in diameter. This encapsulation allows the dye to remain in place, under the skin, after being injected. The researchers designed their dye to be delivered by a microneedle ‘patch’ rather than a traditional syringe and needle. Such patches are now being developed to deliver vaccines for measles, rubella, and other diseases, and the researchers showed that their dye could be easily incorporated into these patches. The microneedles used in this study are made from a mixture of dissolvable sugar and a polymer called PVA, as well as the quantum-dot dye and the vaccine. When the patch is applied to the skin, the microneedles, which are 1.5 millimeters long, partially dissolve, releasing their payload within about two minutes.

By selectively loading microparticles into microneedles, the patches deliver a pattern in the skin that is invisible to the naked eye but can be scanned with a smartphone that has the [infrared] filter removed. The patch can be customized to imprint different patterns that correspond to the type of vaccine delivered. “It’s possible that this ‘invisible’ approach could create new possibilities for data storage, biosensing, and vaccine applications that could improve how medical care is provided, particularly in the developing world,” Langer says.

The quantum-dot patterns could be detected by smartphone cameras after up to five (5) years of simulated sun exposure. The researchers are also working on expanding the amount of data that can be encoded in a single pattern, allowing them to include information such as the date of vaccine administration and the lot number of the vaccine batch. “Storage, access, and control of medical records is an important topic with many possible approaches.” “This study presents a novel approach where the medical record is stored and controlled by the patient within the patient’s skin in a minimally invasive and elegant way.” The research was funded by the Bill and Melinda Gates Foundation and the Koch Institute Support (core) Grant from the National Cancer Institute.

APPLE FACE and PALM ‘INFRARED Photo Detectors’ biometrics planned in 2023 iPhones.

Face ID Infrared biometrics cameras are coming to Apple devices in 2023. A series of patent filings by Apple have hinted at the company’s work on under-display biometric cameras, with the latest published in February (2021).  Apple eyes next-generation biometric scanners for under-display Touch ID. ‘[Infrared photodetectors] could be used for biometric user identification and authentication in the palm or face.’ A new patent application by Apple is signaling the company’s emphasis on biometric ‘photodetector’ technology for under-display touch identification to be potentially deployed on its devices. The sensors include biometric sensors, depth sensors, and cameras. Apple’s listed uses of the photodetectors include security and health monitoring. Arrays of these photodetectors may be deployed to scan fingerprint, palm print, 3D face, or eye biometrics. The [photodetectors could be used for biometric user identification and authentication.] Photodetectors emit electromagnetic radiation against an object such as a finger, face, or stylus. Once reflected by the object, this radiation returns a backscatter which then passes back through the display to register the object’s information. The document also refers to the possibility of using optical, ultrasonic, thermal or other sensing technologies within the system. In addition to this, the photodetectors are also capable of obtaining ophthalmic scans, ECG, and pulse for health monitoring. Other uses of the scanners include palm scanning for social matching and social networking. Apple’s research and development of technology for monitoring health metrics, three patent applications describe [Infrared transceivers] for object recognition. The [infrared transceivers], which may be used in telephones include beam-steering technology and will likely be used for augmented object recognition via visible and [infrared light]. According to the filing, the device can sense objects in a variety of light conditions including visible light, UV, and [infrared spectrum] ranges.

Vaccine INFRARED ‘Micro-Needle SMART Patch’

“Nanocrystals called quantum dots, can remain for at least FIVE (5) years under the skin, forming an ‘image’, where they emit near-[infrared light] that can be detected by a specially equipped smartphone.” (MIT researchers FUNDED by the Bill & Melinda Gates Foundation).

‘Infrared’ Mark of the Beast, 2023 to 2028 = FIVE (5) YEARS.

FIVE (5) is the number denoting Satanic influence over the behavior of evil man’kind (666).

2023 ‘INFRARED’ SMART Phones

2023 ‘INFRARED’ VACCINE MICRO-NEEDLE SMART Patches

Come June, 2021 … 2023 is ONLY 18 (6+6+6) months in the future.

False Prophet

Revelation 13:16-17 And he causeth all, both small and great, rich and poor, free and bond, to [receive a mark IN their right hand, or IN their foreheads]:And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name.

My discernment is that;

2023 will mark the ‘roll-out’ of the ‘MARK’ of the BEAST.

2024 will mark the ‘mid-point’ of the 7 Year Tribulation, the Abomination of Desolation revealing the BEAST to be the ANTICHRIST, the Destruction of ‘Mystery Religion’, the beginning of worshipping the BEAST and his IMAGE, and the ‘BEHEADING’ of those who refuse the  Beast’s MARK, refuse to worship the BEAST or his IMAGE. Until 2024, Christians will be ‘protected’ under the MYSTERY RELIGION doctrine of (5) ‘inter-religious dialogue, brotherhood, human fraternity, coexistence and false religious / political peace.’ Upon the enactment of the Antichrist’s Abomination of Desolation and the abolishment of the Mystery Religion, is when BOTH the Jews will become persecuted and have to flee Jerusalem AND Christians will start to be BEHEADED because they will refuse to get the mark and refuse to worship the BEAST and his IMAGE. Beheadings will last during the FINAL 3.5 years of the Tribulation (Great Tribulation) and cease at the end of 2027. 2028 (8) will usher in the Jew’s REDEMPTION, sheep and goat nations’ judgement, gathering of the remaining ‘elect’ from the four corners of the earth and the beginning of Jesus Christ’s 1,000 Year Millennial Reign upon earth. The Second, Physical Coming of Christ to Earth (Great Day of the Lord and Armageddon) will likely take place near the very end of (fall, on/about November 1, 2027) 2027.

God will NOT let Christ’s Bride be Deceived by the Dragon, or his ‘MARK.’

True Church / Bride of Christ Spared from God’s Wrath:

 Romans 5:8-10. “But God commendeth his love toward us, in that, while we were yet sinners, Christ died for us. Much more then, being now justified by his blood, we shall be saved from wrath through him. For if, when we were enemies, we were reconciled to God by the death of his Son, much more, being reconciled, we shall be saved by his life.”

1 Thessalonians 1:10. And to wait for his Son from heaven, whom he raised from the dead, even Jesus, which delivered us from the wrath to come.

1 Thessalonians 5:9. For God hath not appointed us to wrath, but to obtain salvation by our Lord Jesus Christ,

Romans 8:35. Who shall separate us from the love of Christ? shall tribulation, or distress, or persecution, or famine, or nakedness, or peril, or sword?

Jeremiah 30:7. Alas! for that day is great, so that none is like it: it is even the time of Jacob’s trouble, but he shall be saved out of it.

Revelation 3:10 Because thou hast kept the word of my patience, I also will keep thee from the hour of temptation, which shall come upon all the world, to try them that dwell upon the earth.

The ‘mark’ comes shortly, during the tribulation, but the Bride is ‘not here.’ The ‘current’ vaccine(s) are NOT the mark, yet. But they are a ‘precursor’ (‘NORMALIZATION’) of the beast system process, getting people accustomed to getting ‘tagged’, ‘marked’ or ‘branded.’

CDMOs Gear Up to Churn Out Cell and Gene Therapies. ‘As in the days of Noah, ALL FLESH had become corrupted, defiled or unclean.’

Encouraged by optimistic market scenarios for cell and gene therapies, CDMOs are implementing technologies to speed development and facilitate scale-up

By Gareth John Macdonald  August 2, 2021 Genetic Engineering and Biotechnology News

Ever alert to new opportunities, contract development and manufacturing organizations (CDMOs) are well aware that cell and gene therapies are generating excitement among industry analysts. For example, Deloitte recently predicted that the cell and gene therapy market will generate revenues of $12 billion a year by 2025, which is an impressive jump for a market valued at just $1 billion three years ago. Deloitte indicated that its prediction was based on the high level of activity in cell and gene therapy R&D—more than 1,000 clinical trials were ongoing in 2019—and the large number of developers entering the space.

Whether such growth actually occurs will depend on whether cell and gene therapies can be developed and manufactured efficiently, suggests Travis Whitfill, PhD, a partner at biotech venture capital firm Bios Partners. He insists that bioprocessing technologies such single-use and in-line processing technologies will need to be implemented more widely.

This view is shared by Nitin Naik, healthcare and life sciences global business leader at Frost & Sullivan. “The need to launch innovative therapies such as cell and gene therapies more quickly and economically has pushed industry to innovate, he notes. “The ability to step up manufacturing in terms of its productivity and scale-up across global sites is critical.”

Importance of outsourcing

In the small-molecule and traditional biologics sectors, the main way to accelerate development and increase scale has been to outsource production. And outsourcing is also used in the cell and gene therapy space.

“There’s an increasing tendency to outsource because biopharma companies have limited resources,” explains Whitfill. “In many cases, they would like to allocate those resources to activities like R&D instead of manufacturing.”

However, the production of cell and gene therapies is more complex than that of small-molecule drugs, particularly in terms of achieving consistency. As a result, it is important that developers looking to outsource to CDMOs also work with technology suppliers to make sure production is consistent.

“Technology suppliers have a big role to play to influence biopharmaceutical companies in adopting a process simplification mindset,” Naik points out. “Suppliers are leveraging advanced materials or analytical tools to expand bioprocessing applications to a wide range of conditions and improve portability of the processes.”

AI-based production processes are an example. “There are several proof-of-concepts using AI and machine learning that have demonstrated reductions in manufacturing cost or higher productivity,” Naik elaborates. “However, these approaches rely on consistent equipment performance and access to sophisticated process analytical tools. Equipment performance variation across global sites remains a challenge, and so does integration. So, platform ability is the biggest barrier.”

Advantages of a technology-agnostic approach

Charles River Laboratories (CRL), long known as a research services firm, says that it is expanding its manufacturing business while pursuing a “technology agnostic” strategy that emphasizes innovation and flexibility. In March, for example, CRL bought Cognate BioServices and its subsidiary Cobra Biologics to add cell and gene therapy production capabilities and capacity. And in May, CRL announced another acquisition in the production services space, unveiling a plan to buy gene-therapy-focused CDMO Vigene Biosciences.

With the Cognate and Vigene acquisitions, CRL may reorient its manufacturing business to serve a different mix of biopharma companies. It may also embrace new technologies.

“[We are adding Cognate’s and Vigene’s] premier development and manufacturing capabilities to our existing expertise,” says Mike Austin, corporate vice president, Global Operations Cell and Gene Therapy CDMO Services, CRL. “[Our combined capabilities allow] clients to bring their cell and gene therapies from early research and discovery all the way through commercialization in a single, streamlined program.”

“The extent to which Cognate’s manufacturing operations are digitized is largely process and client dependent,” he continues. “We purposefully keep our operations technology agnostic, so the manufacturing process can be tailored to specific client needs: each client specifies which equipment they would like to use, leading to some being very closed and automated, while some are open and manual.”

Austin emphasizes that the collation, management, and application of manufacturing process data is core to Cognate’s strategy: “Across the organization, Cognate has implemented a number of technologies to standardize and automate operations. We utilize an electronic documentation system, which also handles deviation and Corrective Action and Preventive Action (CAPA) procedures. In the labs, there is an electronic laboratory information management system that produces the final Certificate of Analysis used in final batch release.”

Cognate is adept at leveraging partnerships. Last year, for example, it partnered with L7 Informatics to deploy L7’s Enterprise Science Platform (ESP) and implement an integrated manufacturing and lab system. ESP is a unified data and process automation platform covering manufacturing, quality control, clinical operations, and real-time process intelligence products powered by Microsoft PowerBI.

“Due to the complexities associated with multiproduct facilities and cell and gene manufacturing processes, Cognate required a bimodal, composable platform to provide both a flexible and comprehensive electronic solution,” Austin explains. He adds that ESP provides Cognate with the ability to host various CDMO workflows and adapt existing models to fit projects.

According to Austin, CRL plans to use ESP to enable Cognate’s digital twin technology, a real-time digital manufacturing process model, to apply machine learning and data science methods to self-optimize, self-correct, and automate manufacturing operations.

CRL will also leverage relationships with suppliers ensure its manufacturing business caters to the full range of customer demands. “Innovative manufacturing technologies are driven through relationships with key suppliers,” says Austin. He cites Cognate’s partnerships (through Cobra) with bioprocessing systems firm Cytiva, as well as Cognate’s viral vector–focused deal with Pall, to suggest how the firm monitors innovation. “As an organization,” he declares, “we will perform proof-of-concept work with our partners to make strategic, informed recommendations on how our clients should set up their processes.”

Nonviral transfection technology

Transfection methods include electroporation, nanoparticle-based methods, and viral vector–based methods. The choice depends on both the nature of the project and the target cell involved.

And therein lies the challenge. Some cell lines are more difficult to work with than others, according to Nina Novak, PhD, a product manager at the Swiss CDMO Lonza. “Most primary cells … are harder to transfect than [production] cell lines,” she says. “Basically, there are no one-fits-all conditions to transfect primary cells, which makes the optimization process time consuming.

“However, even some [production] cell lines need enhanced transfection conditions. Cells relevant for cell therapeutic approaches, usually blood or stem cells, are notoriously hard to transfect. In addition, many cell therapeutic approaches require quite complex transfection scenarios.”

These include instances in which gene editing techniques are used, or in which several cargos of different molecules need to be transferred in parallel. Similar challenges are faced if chimeric antigen receptor (CAR) T cells are generated using transposon/transposase-based systems, or if induced pluripotent stem cells are reprogrammed using episomal vectors.

“This can be challenging when using chemical transfection reagents,” Novak elaborates. “Also, viral approaches can have their limitations, be it in insert size, co-transduction capabilities, cargo flexibility, production costs, insertional mutagenesis, or immunogenicity.”

So, while most cell and gene therapy firms use vectors, many also examine alternative transfection approaches. “Despite the fact that a big proportion of cell therapies are developed based on viral approaches, nonviral approaches are often pursued in parallel,” Novak tells GEN. “Drivers behind adopting a nonviral approach are most likely cost and safety reasons. For cell and gene therapy applications, there is a demand to transfect high cell numbers with high efficiency without being dependent on viral vectors.”

Lonza’s vector alternative is its Nucleofactor platform. The system—which celebrates its 20th anniversary this year—is an electroporation device that delivers a pulse to the target cell, prompting the uptake of DNA.

“The electrical pulses allow for DNA transfer directly into the nucleus,” Novak says. “Therefore, gene expression after transfection can be observed in four hours or less. Other transfection methods depend on breakdown of the nucleic membrane for DNA uptake into the nucleus and subsequent gene expression.”

A recent iteration of the platform is known as the 4D Nucleofector system. It can transfect up to one billion cells in one experiment. “This high cell number is suited especially for autologous cell therapy applications,” she asserts. “Researchers can optimize their experiments in small scale and transfer these conditions to their high-cell-number clinical applications; this can bring a competitive advantage in the development of therapies.”

In cell therapy manufacturing, transfection choices also affect the upscaling of processes that typically occurs when processes are transferred from development to manufacturing. Lonza’s system was designed with this kind of upscaling in mind, according to Novak, who says “Transfection protocols established on the existing smaller-scale unit can be smoothly transferred to the new large-scale unit without the need for reoptimization.”

Several of Lonza’s customers are running clinical trials using Nucleofector Technology, including researchers led by the U.S. National Cancer Institute in a Phase I study using CAR-T therapies to treat B-cell malignancies.

Matthew 24:37

But as the days of Noah were, so shall also the coming of the Son of man be.

8 References to ‘BE WATCHING or WATCHFUL.’ ‘8’ indicates that a new ‘era or epoch’ is arriving. Be it the rapture, the tribulation, the year of the Jews redemption or the year of the onset (2028) of the 1000 year millennial reign of Christ (2028-3028).

Matthew 24:42; Watch therefore: for ye know not what hour your Lord doth come.

Matthew 25:13; Watch therefore, for ye know neither the day nor the hour wherein the Son of man cometh.

Mark 13:35; Watch ye therefore: for ye know not when the master of the house cometh, at even, or at midnight, or at the cockcrowing, or in the morning.

Luke 21:36; Watch ye therefore, and pray always, that ye may be accounted worthy to escape all these things that shall come to pass, and to stand before the Son of man

Luke 12:37-39; Blessed are those servants, whom the lord when he cometh shall find watching: verily I say unto you, that he shall gird himself, and make them to sit down to meat, and will come forth and serve them. And if he shall come in the second watch, or come in the third watch, and find them so, blessed are those servants. And this know, that if the goodman of the house had known what hour the thief would come, he would have watched, and not have suffered his house to be broken through.

 ‘Increasing Like Labor Pains.’ ‘Fearful Sights.’ ‘Perilous Times.’ ‘Men’s hearts failing with fear.’ Great Convergence of Signs.’ REDEMPTION IMMINENT.

In His Service,

Night Watchman

Paul Rolland

Night Watchman Ministries

Make Your Decision for Christ NOW!!!!!!! Time is Up!!!!!!!

Jesus Christ’s Offer of Salvation:

The ABCs of Salvation through Jesus Christ (the Lamb)

A. Admit/Acknowledge/Accept that you are sinner. Ask God’s forgiveness and repent of your sins.

. . . “For all have sinned, and come short of the glory of God.” (Romans 3:23).

. . . “As it is written, There is none righteous, no, not one.” (Romans 3:10).

. . . “If we say that we have no sin, we deceive ourselves, and the truth is not in us.” (1 John 1:8).

B. Believe Jesus is Lord. Believe that Jesus Christ is who He claimed to be; that He was both fully God and fully man and that we are saved through His death, burial, and resurrection. Put your trust in Him as your only hope of salvation. Become a son or daughter of God by receiving Christ.

. . . “That whosoever believeth in him should not perish, but have eternal life. For God so loved the world, that he gave his only begotten Son, that whosoever believeth in him should not perish, but have everlasting life. For God sent not his son into the world to condemn the world; but that the world through him might be saved. (John 3:15-17). For whosoever shall call upon the name of the Lord shall be saved.” (Romans 10:13).

C. Call upon His name, Confess with your heart and with your lips that Jesus is your Lord and Savior.

. . . “That if thou shalt confess with thy mouth the Lord Jesus, and shalt believe in thine heart that God hath raised him from the dead, thou shalt be saved. For with the heart man believeth unto righteousness; and with the mouth confession is made unto salvation.” (Romans 10:9-10).

. . . “If we say that we have no sin, we deceive ourselves, and the truth is not in us. If we confess our sins, he is faithful and just to forgive us our sins, and to cleanse us from all unrighteousness. If we say that we have not sinned, we make him a liar, and his word is not in us.” (John 1:8-10).

. . . “And he is the propitiation for our sins: and not for ours only, but also for the sins of the whole world. (John 2:2).

. . . “In this was manifested the love of god toward us, because that God sent his only begotten Son into the world, that we might live through him. And we have seen and do testify that the Father sent the Son to be the Saviour of the world. Whosoever shall confess that Jesus is the Son of God, God dwelleth in him, and he in God.” (1 John 4:9, 14-15).

. . . “But God commendeth his love toward us, in that, while we were yet sinners, Christ died for us. Much more then, being now justified by his blood, we shall be saved from wrath through him. For if, when we were enemies, we were reconciled to God by the death of his Son, much more, being reconciled, we shall be saved by his life.” (Romans 5:8-10).

. . . “For the wages of sin is death; but the gift of God is eternal life through Jesus Christ our Lord.” (Romans 6:23).

. . . “Jesus saith unto them, I am the way, the truth, and the life, no man cometh unto the Father, but by me.” (John 14:6).

. . . “For I am not ashamed of the gospel of Christ: for it is the power of God unto salvation to everyone that believeth.” (Romans 1:16).

. . . “Neither is there salvation in any other: for there is none other name under heaven given among men, whereby we must be saved.” (Acts: 4:12).

. . . “Who will have all men to be saved, and to come unto the knowledge of the truth for there is one God, and one mediator between God and men, the man Christ Jesus.” (1 Timothy 2:4-6).

. . . “For God did not appoint us to suffer wrath but to receive salvation through our Lord Jesus Christ.” (1 Thessalonians 5:9).

. . . “But as many as received him, to them gave the power to become the sons of God, even to them that believe on his name.” (John 1:12).

True Church / Bride of Christ Spared from God’s Wrath:

 Romans 5:8-10. “But God commendeth his love toward us, in that, while we were yet sinners, Christ died for us. Much more then, being now justified by his blood, we shall be saved from wrath through him. For if, when we were enemies, we were reconciled to God by the death of his Son, much more, being reconciled, we shall be saved by his life.”

Romans 12:19. Dearly beloved, avenge not yourselves, but rather give place unto wrath: for it is written, Vengeance is mine; I will repay, saith the Lord.

1 Thessalonians 1:10. And to wait for his Son from heaven, whom he raised from the dead, even Jesus, which delivered us from the wrath to come.

1 Thessalonians 5:9. For God hath not appointed us to wrath, but to obtain salvation by our Lord Jesus Christ,

Romans 8:35. Who shall separate us from the love of Christ? shall tribulation, or distress, or persecution, or famine, or nakedness, or peril, or sword?

Jeremiah 30:7. Alas! for that day is great, so that none is like it: it is even the time of Jacob’s trouble, but he shall be saved out of it.

Revelation 3:10 Because thou hast kept the word of my patience, I also will keep thee from the hour of temptation, which shall come upon all the world, to try them that dwell upon the earth.

Leave a Reply